Abstract
Introduction: Respiratory compromise in Pompe disease is one of the most frequent manifestations, which has a negative impact on quality of life and leads to multiple complications. This can occur as an evolutionary part of the disease, or even be the initial symptom of the pathology.
Contents: Its clinical presentation is characterized by dyspnea, orthopnea, headache, and cough, and its paraclinical changes include hypercapnia, polycythemia, elevated apnea/hypopnea index, decreased vital capacity, and decreased maximum inspiratory and expiratory pressures. Respiratory compromise is caused mainly by muscular dysfunction (especially the diaphragm) and alteration of regulation of the central nervous system.
Conclusions: An initial careful assessment of respiratory patterns is essential, and of course their follow-up, that will depend of the type of progression of respiratory dysfunction (rapid or slow) or the specific requirement for each patient (non-invasive or invasive ventilation).
References
Angelini C, Semplicini C, Ravaglia S, Moggio M, Comi GP, Musumeci O, et al. New motor outcome function measures in evaluation of late-onset Pompe disease before and after enzyme replacement therapy. Muscle Nerve 2012;45(6):831-4. https://doi.org/10.1002/mus.23340
Carlier RY, Laforet P, Wary C, Mompoint D, Laloui K, Pellegrini N, et al. Whole-body muscle MRI in 20 patients suffering from late onset Pompe disease: involvement patterns. Neuromuscul Disord. 2011;21(11):791-9. https://doi.org/10.1016/j.nmd.2011.06.748
Zsolt I, Mike A, Trauninger A, Vardi K, Vaczi M. Motor function and respiratory capacity in patients with late-onset Pompe disease. Muscle Nerve. 2014;49(4):603-6. https://doi.org/10.1002/mus.24142
Mellies U, Lofaso F. Pompe disease: a neuromuscular disease with respiratory muscle involvement. Respir Med. 2009;103(4):477-84. https://doi.org/10.1016/j.rmed.2008.12.009
Mellies U, Stehling F, Dohna-Schwake C, Ragette R, Teschler H, Voit T. Respiratory failure in Pompe disease: treatment with noninvasive ventilation. Neurology. 2005;64(8):1465-7. https://doi.org/10.1212/01.WNL.0000158682.85052.C0
Hogan GR, Gutmann L, Schmidt R, Gilbert E. Pompe's disease. Neurology. 1969;19(9):894-900. https://doi.org/10.1212/WNL.19.9.894
Hagemans ML, Winkel LP, Hop WC, Reuser AJ, Van Doorn PA, Van der Ploeg AT. Disease severity in children and adults with Pompe disease related to age and disease duration. Neurology. 2005;64(12):2139-41. https://doi.org/10.1212/01.WNL.0000165979.46537.56
Haley SM, Fragala MA, Skrinar AM. Pompe disease and physical disability Dev Med Child Neurol. 2003;45(9):618-23. https://doi.org/10.1111/j.1469-8749.2003.tb00966.x
Hirschhorn R, Huie ML. Frequency of mutations for glycogen storage disease type II in different populations: the delta525T and deltaexon 18 mutations are not generally common in white populations. J Med Genet. 1999;36(1):85-6.
Mellies U, Ragette R, Schwake C, Baethmann M, Voit T, Teschler H. Sleep-disordered breathing and respiratory failure in acid maltase deficiency. Neurology. 2001;57(7):1290-5. https://doi.org/10.1212/WNL.57.7.1290
Pellegrini N, Laforet P, Orlikowski D, Pellegrini M, Caillaud C, Eymard B, Raphael JC, Lofaso F. Respiratory insufficiency and limb muscle weakness in adults with Pompe's disease. Eur Respir J. 2005;26(6):1024-31. https://doi.org/10.1183/09031936.05.00020005
Prigent H, Orlikowski D, Laforet P, Letilly N, Falaize L, Pellegrini N, Annane D, Raphael JC, Lofaso F. Supine volume drop and diaphragmatic function in adults with Pompe disease. Eur Respir J. 2012;39(6):1545-6. https://doi.org/10.1183/09031936.00169011
Jones H, Hobson-Webb L, Kuchibhatla M, Crisp K, Whyte-Rayson A, Batten M, Zwelling P, Kishnani P. Tongue weakness and atrophy differentiates late-onset Pompe disease from other forms of acquired/hereditary myopathy, Molecular Genetics and Metabolism. 2021;133(3):261-268. https://doi.org/10.1016/j.ymgme.2021.05.005
Dubrovsky A, Corderi J, Lin M, Kishnani PS, Jones HN. Expanding the phenotype of late-onset Pompe disease: tongue weakness: a new clinical observation. Muscle Nerve. 2011;44(6):897-901. https://doi.org/10.1002/mus.22202
Margolis ML, Howlett P, Goldberg R, Eftychiadis A, Levine S. Obstructive sleep apnea syndrome in acid maltase deficiency. Chest. 1994;105(3):947-9. https://doi.org/10.1378/chest.105.3.947
Bellettato CM, Scarpa M. Pathophysiology of neuropathic lysosomal storage disorders. J Inherit Metab Dis. 2010;33(4):347-62. https://doi.org/10.1007/s10545-010-9075-9
DeRuisseau LR, Fuller DD, Qiu K, DeRuisseau KC, Donnelly WH Jr, Mah C, Reier PJ, Byrne BJ. Neural deficits contribute to respiratory insufficiency in Pompe disease. Proc Natl Acad Sci U S A. 2009;106(23):9419-24. https://doi.org/10.1073/pnas.0902534106
Sidman RL, Taksir T, Fidler J, Zhao M, Dodge JC, Passini MA, Raben N, Thurberg BL, Cheng SH, Shihabuddin LS. Temporal neuropathologic and behavioral phenotype of 6neo/6neo Pompe disease mice. Neuropathol Exp Neurol. 2008;67(8):803-18. https://doi.org/10.1097/NEN.0b013e3181815994
Fuller DD, ElMallah MK, Smith BK, Corti M, Lawson LA, Falk DJ, Byrne BJ. The respiratory neuromuscular system in Pompe disease. Respir Physiol Neurobiol. 2013;189(2):241-9. https://doi.org/10.1016/j.resp.2013.06.007
https://doi.org/10.1016/j.resp.2013.06.007Feldman JL, Mitchell GS, Nattie EE. Breathing: rhythmicity, plasticity, chemosensitivity. Annu Rev Neurosci. 2003;26:239-66. https://doi.org/10.1146/annurev.neuro.26.041002.131103
Musumeci O, Catalano N, Barca E, Ravaglia S, Fiumara A, Gangemi G, Rodolico C, Sorge G, Vita G, Galletti F, Toscano A. Auditory system involvement in late onset Pompe disease: a study of 20 Italian patients. Mol Genet Metab. 2012;107(3):480-4. https://doi.org/10.1016/j.ymgme.2012.07.024
Begin R, Bureau MA, Lupien L, Lemieux B. Control and modulation of respiration in Steinert's myotonic dystrophy. Am Rev Respir Dis. 1980;121(2):281-9, https://doi.org/10.1164/arrd.1980.121.2.281
Johnson DC, Kazemi H. Central control of ventilation in neuromuscular disease. Clin Chest Med. 1994;15(4):607-17. https://doi.org/10.1016/S0272-5231(21)00956-4
Aruj PK, Monteiro SG, De Vito EL. Analysis of factors associated with chronic hypercapnia in patients with myotonic dystrophy. Medicina (B Aires)- 2013;73(6):529-34.
Borel CO, Teitelbaum JS, Hanley DF. Ventilatory drive and carbon dioxide response in ventilatory failure due to myasthenia gravis and Guillain-Barre syndrome. Crit Care Med. 1993;21(11):1717-26. https://doi.org/10.1097/00003246-199311000-00022
Whitelaw WA, Derenne JP, Milic-Emili J. Occlusion pressure as a measure of respiratory center output in conscious man. Respir Physiol. 1975;23(2):181-99. https://doi.org/10.1016/0034-5687(75)90059-6
Whitelaw WA, Derenne JP. Airway occlusion pressure. J Appl Physiol (1985). 1993;74(4):1475-83. https://doi.org/10.1152/jappl.1993.74.4.1475
Hobson-Webb LD, Proia AD, Thurberg BL, Banugaria S, Prater SN, Kishnani PS. Autopsy findings in late-onset Pompe disease: a case report and systematic review of the literature. Mol Genet Metab. 2012;106(4):462-9. https://doi.org/10.1016/j.ymgme.2012.05.007
Echaniz-Laguna A. Should patients with asymptomatic Pompe disease be treated? A nationwide study in France. Muscle Nerve. 2015;51(6):884-9. https://doi.org/10.1002/mus.24653
El-Gharbawy AE, Bhat G, Murillo JE, Thurberg BL, Kampmann C, Mengel KE, et al. Expanding the clinical spectrum of late-onset Pompe disease: dilated arteriopathy involving the thoracic aorta, a novel vascular phenotype uncovered. Mol Gen Metab 2011;103(4):362-6. https://doi.org/10.1016/j.ymgme.2011.04.009
Voduc N, Webb K, O'Donnel D. Physiological basis of dyspnoea. En: Donner CF, Ambrosino N, Goldstein R, editores. Pulmonary rehabilitation. Londres: Hodder Arnold; 2005. p. 124e35. https://doi.org/10.1201/b13288-16
Parshall MB, Schwartzstein RM, Adams L, Banzett RB, Manning HL, Bourbeau J, et al. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med. 2012;185(4):435e52. https://doi.org/10.1164/rccm.201111-2042ST
Mahler DA. Measurement of dyspnea. En: Donner CF, Ambrosino N, Goldstein R, editores. Pulmonary rehabilitation. Londres: Hodder Arnold; 2005. p. 136e42.
Ambrosino N, Carpene N, Gherardi M. Chronic respiratory care for neuromuscular diseases in adults. Eur Respir J. 2009;34(2):444e51. https://doi.org/10.1183/09031936.00182208
Culebras A. Sleep disorders and neuromuscular disease. Semin Neurol. 2005;25(1):33e8. https://doi.org/10.1055/s-2005-867071
Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, et al. Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. Lancet Neurol. 2010;9(2):177e89. https://doi.org/10.1016/S1474-4422(09)70272-8
Wang CH, Bonnemann CG, Rutkowski A, Sejersen T, Bellini J, Battista V, et al. Consensus statement on standard of care for congenital muscular dystrophies. J Child Neurol. 2010;25(12):1559e81. https://doi.org/10.1177/0883073810381924
Nickol AH, Hart N, Hopkinson NS, Moxham J, Simonds A, Polkey MI. Mechanisms of improvement of respiratory failure in patients with restrictive thoracic disease treated with non- invasive ventilation. Thorax. 2005;60(9):754e60. https://doi.org/10.1136/thx.2004.039388
Ambrosino N, Confalonieri M, Crescimanno G, Vianello A, Vitacca M. The role of respiratory management of Pompe disease. Respir Med. 2013;107(8):1124-32. https://doi.org/10.1016/j.rmed.2013.03.004
Varon-Vega F, Giraldo A. Fisiología de la ventilación mecánica no invasiva. Rev Colomb Neumol. 2016;28(1):24-32. https://doi.org/10.30789/rcneumologia.v28.n1.2016.161
Crescimanno G, Marrone O, Vianello A. Efficacy and comfort of volume-guaranteed pressure support in patients with chronic ventilatory failure of neuromuscular origin. Respirology 2011;16(4):672e9. https://doi.org/10.1111/j.1440-1843.2011.01962.
Smith BK, Fuller DD, Martin AD, Lottenberg L, Islam S, Lawson LA, Onders RP, Byrne BJ. Diaphragm pacing as a rehabilitative tool for patients with pompe disease who are ventilator-dependent: case series. Phys Ther. 2016;96(5):696-703. https://doi.org/10.2522/ptj.20150122
Aslan GK, Huseyinsinoglu BE, Oflazr P. Inspiratory muscle training in late-onset Pompe disease: the effects on pulmonary function tests, quality of life, and sleep quality. Lung. 2016;194(4):555-61. https://doi.org/10.1007/s00408-016-9881-4
Steier J, Jolley CJ, Seymour J, Teschler H, Luo YM, Polkey MI, Moxham J. Screening for sleep- disordered breathing in neuromuscular disease using a questionnaire for symptoms associated with diaphragm paralysis. Eur Respir J 2011;37(2):400-5. https://doi.org/10.1183/09031936.00036210
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.